Chinese hospital chain operator BangEr Orthopedic has raised a RMB300 million ($46 million) Series D round led by Fortune Capital and Cenova Capital.
Healthcare, rather than “rocket science,” represents the biggest opportunity for artificial intelligence (AI) applications, according to Kai-Fu Lee, chairman and CEO of China’s Sinovation Ventures.
Experiences vary across geographies as Asian GPs adapt to pandemic working conditions. Technology use is up, but the most lasting changes may be more cultural in nature.
ORI Capital’s 2.8x return on its investment in Kymab was in part based on helping the company make the transition from antibody-based discovery platform to drug development engine
A fourth-quarter surge in growth-stage deal-making took Asia private equity investment to $198.5 billion in 2020, comfortably surpassing the previous year’s total despite the strictures of COVID-19.
Lei Zhang, founder and CEO of Hillhouse Capital, emphasized the opportunities at the nexus of life sciences and artificial intelligence-enabled supercomputing, while describing his firm as “probably the largest investor in healthcare in China.”
Lake Bleu Capital, a Hong Kong-based private equity investor focused on healthcare, has raised $560 million for a pre-IPO fund targeting Asia with an emphasis on Greater China.
Tencent Holdings and Trustbridge Partners have led a $100 million Series C funding round for Jiliguala, a Shanghai-based online English learning platform.
A year after leaving Qiming Venture Partners, J.P. Gan raised $351.9 million for his debut fund at consumer internet-focused Ince Capital Partners
Playtika, an Israel-headquartered social and mobile games company that was acquired by a PE-backed Chinese consortium in 2016, gained 17% on its US trading debut following a $1.88 billion IPO.
Chinese mapping start-up Wayz.ai has raised $40 million in an extended Series A round from a range of local investors.
Firstred Capital, a Chinese private equity firm established by M&A veteran Xiaodan Liu, is looking to raise approximately $500 million for its debut US dollar-denominated fund.
Whether it is building a logistics platform, backing a take-private or anchoring a growth round for a tech start-up, Warburg Pincus prioritizes local partnerships in Asia
The proposal to place a 0% tax on carried interest has been welcomed in Hong Kong, but PE industry participants are quietly looking to Hong Kong Monetary Authority to ensure balanced execution of the policy
Technology and healthcare-focused Oceanpine Capital sees the large GP commitment to its fund and the network of its founder as key differentiators in a competitive Chinese market
Chinese industrial robot manufacturer Jaka Robotics has raised RMB300m ($46m) in Series C funding led by CPE and State Development and Investment Corporation (SDIC).
A special purpose acquisition company (SPAC) sponsored by Liang Meng, founding managing partner of China’s Ascendent Capital Partners, has raised $300 million for global consumer technology investments.
Chinese autonomous driving start-up WeRide has raised $310 million in Series B funding across three tranches led by Chinese electric bus manufacturer Yutong Group.
Morgan Stanley Private Equity Asia helped ethical Greek cosmetics maker Korres beef up an underweight international presence with a plan that will see China become the main growth engine
Asia could prove to be a deal-rich market in 2021, but buyout investors are still figuring out the long-term implications of COVID-19 for companies that cater to changing consumer demands
CICC Capital has reached a second close of RMB4.2 billion ($650 million) on its latest healthcare fund - the first in China to receive fast-track approval for its role in addressing COVID-19.
Hong Kong healthcare-focused VC firm ORI Capital has reached a first close of $112 million on its second fund and exited its largest investment, UK biotech developer Kymab, as part of a $1.1 billion deal.
Cathay Capital has raised EUR650 million ($789 million) for its second innovation fund, which supports start-ups in China, Europe, and North America.
WorkTrans, a Chinese human resources services provider, has raised $190 million through two tranches, a Series C of $50 million and a Series D of $140 million.